Opening the Door for New Treatment Options
Cerebral Palsy (CP) is a condition that affects the body’s ability to control movements and posture. This condition affects motor development and results in a life of physical disability. Having Cerebral Palsy means having to learn to live with a challenge that will impact the quality of life for the individual and create an emotional and financial burden for the family. Current therapies focus on rehabilitation and offer temporary relief. There is an urgent need for new therapies and innovations to improve the situation and address the real challenges faced by the individuals. Regenerative medicine is an area of rapid innovation and improvement that may offer the potential for real recovery. It is one of the few avenues that can offer real and extensive neural restoration. Repairing the deficits of neurology at the dedicated Stem Cell Clinic addresses one of the greatest barriers to recovery by offering the potential to repair the injured neural networks with the use of UC-MSCs. This is a paradigm shift in regenerative medicine as the focus is no longer on the relief and management of chronic symptoms.
The Therapeutic Mechanism of UC-MSCs
Unlike other therapies provided at a Stem Cell Clinic, the UC-MSCs’ therapeutic potential for Cerebral Palsy rests on their ability to modify intercellular communication networks. Following their use, these MSCs can travel to areas of neuroinflammation and begin to release their therapeutic and bio modulatory agents. While the secretome is known to have a wide range of biomolecules, a fundamental aspect of their mechanism relies on a paracrine signaling cascade and the release of neurotrophic factors (NFs) and brain-derived NFs.
Administered at a Stem Cell Clinic, these innovative UC-MSCs therapies trigger powerful immunomodulatory effects via local macrophage repolarization to a beneficial anti-inflammatory macrophage phenotype. The immunomodulatory effects reduce harmful glial scarring and promote regeneration of axons. The dynamic interactions at the site promote the restoration of neural circuits and improved motor function for those with Cerebral Palsy through the enhancement of synaptic plasticity.
Limitations of Current Therapies
Current medical therapies for patients with Cerebral Palsy do not target the primary injury to the brain. Medical practitioners prescribe oral anti-spasmodic drugs to provide relief from the spasticity of muscles. The goal of intensive physical and occupational therapy is to prevent the formation of painful permanent muscle contractures. Lengthening tendon surgeries must correct permanent distortions of the skeleton. In spite of the extensive multidisciplinary effort, the primary ischemic injury to the brain remains. Pharmacotherapy causes the adverse effects of weakness and chronic fatigue. Surgical interventions are limited by the risks and chronic pain of the postoperative period. Unlike the UC-MSCs provided at a Stem Cell Clinic, current therapeutic modalities do not restore lost neural pathways, and patients with Cerebral Palsy remain permanently impaired and require lifelong institutional care.
The integration of regenerative cellular therapy
The integration of regenerative cellular components is a viable option for the permanent restoration of function for patients with severe neurological impairment, such as Cerebral Palsy. The viable option is the use of umbilical cord-derived mesenchymal stem cells (UC-MSCs) as they are safe for use even in the absence of a match due to their immune privileged state, and can be used in an allogeneic context. When patients seek therapy from an accredited Stem Cell Clinic, they provide a therapeutic intervention that has the potential to rewrite the neural healing process. These biological UC-MSCs, administered at a Stem Cell Clinic, demonstrate a unique ability to traverse the blood-brain barrier and access the central nervous system. Once there, they begin to release anti-apoptotic signaling molecules to shield the surviving neurons from further damage. They also promote the creation of new blood vessels to deliver nutrients to formerly ischemic tissue and to treat Cerebral Palsy.
Figure 1: Limitations of Current Therapies and The integration of regenerative cellular therapy in Cerebral Palsy
Advanced Regenerative Medicine in Thailand
Thailand is now the premier country in the world for medical tourism and especially for regenerative medicine. The country possesses a unique combination of laboratory researchers, a progressive government with a strong regulatory control on biomedical research, and a number of state-of-the-art clinical processing facilities. A leading Stem Cell Clinic in Thailand offers medical tourists the first and only access to safe and regulatory controlled pharmaceutical-grade UC-MSCs therapy. The government of Thailand is very supportive of novel biomedical research and offers a robust scientific framework to help translational research move from the laboratory to the clinic very quickly. Because of this, patients from all over the world seek this country to help treat Cerebral Palsy.
Final Thoughts
There has never been a better time to be a child with a severe neurological condition due to the rapid advancement of regenerative medicine. While the life of a child with Cerebral Palsy is very difficult, new cellular technologies like UC-MSCs from a dedicated Stem Cell Clinic help pave the road to give children with this condition hope of improved functioning. Conventional therapies are aimed at temporary relief of the physical limitations of patients. Advanced regenerative techniques focus on the primary neurological injuries Along the therapeutic spectrum of UC-MSCs, clinicians are able to purposefully resolve chronic neuroinflammation, initiate neural tissue repair, and enhance neural relational growth for conditions like Cerebral Palsy. Thailand is and will be the leader and at the center of this medical revolution. Thailand provides a premier quality Stem Cell Clinic with specialized medical staff and advanced treatments readily available for patients. With this novel biomedical technique, patients no longer have a dismal prognosis of managing their symptoms for the remainder of their lives. Rather, these patients experience a real, long-term recovery from their neurological ailments.